Phase II study of cetuximab plus S-1/cisplatin therapy in Japanese patients with advanced gastric cancer

ConclusionsOverall, the addition of cetuximab to S-1 plus cisplatin was well tolerated in patients with advanced gastric cancer but provided no additional clinical benefit in this study.ClinicalTrials.govidentifier: NCT01388790.
Source: Japanese Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research